相关实验视频

Updated: May 9, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

一个快速的0/1小时算法,用于怀疑非ST段升高心肌梗塞,使用高灵敏度的心脏托罗素I

Junwen Chen¹, Hui Yuan², Qingmao Geng³

¹Department of Emergency and Critical Care Center, Beijing AnZhen Hospital, Capital Medical University, Beijing, China.

NPJ cardiovascular health

|March 3, 2026

概括

为中国患者开发了一种针对高灵敏度心脏托罗邦素I接入 (hs-cTnI-Access) 的新算法. 这种算法提高了非ST段升高心肌梗塞 (NSTEMI) 的诊断准确性,提高了患者的安全性和治疗疗效.

科学领域:

心脏病学心脏病学
生物标志物研究生物标志物研究
临床诊断临床诊断临床诊断

背景情况:

非ST段升高心肌梗塞 (NSTEMI) 诊断依赖于心脏生物标志物.
现有的算法可能需要针对不同患者群体进行优化.
高灵敏度的心脏托罗宁测定提供了更好的诊断潜力.

研究的目的:

开发和验证一款针对中国患者的新型高灵敏心脏托罗因I接入 (hs-cTnI-Access) 0/1h算法.
为了提高hs-cTnI-Access的诊断性能和临床实用性,在此群体中怀疑NSTEMI病例.
将新算法的有效性与现有标准进行比较,例如ESC 0/1h算法.

主要方法:

一项多中心研究涉及369名疑似NSTEMI患者.
开发一个调整的hs-cTnI-Access 0/1h算法,使用特定的规则入和规则外切线值.
统计分析以确定算法的负预测值 (NPV),灵敏度,正预测值 (PPV) 和特异性.

主要成果:

安hs-cTnI-Access 0/1h算法显示了高的NPV为99.46%和98.81%的灵敏度.
该算法实现了PPV为86.42%和特异性为96.14%.
在被研究的人群中,性能指标优于欧洲心脏病学会 (ESC) 0/1h算法.

结论:

新推出的hs-cTnI-Access 0/1h-算法,针对中国患者进行调整,显示出显著的前景.
这种算法有可能提高中国人NSTEMI的诊断安全性和有效性.
进一步的验证和实施可能会在这个人群中完善NSTEMI管理.

更多相关视频

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury

Published on: November 28, 2025

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Acute Coronary Syndrome IV: Interprofessional Care

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...